๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
the study intends to observe the outcome of interventions (concentrated gro...
Status
Unknown
Location
Dow University of health sciences
Start Date
2020-12-17
Trial ID
NCT05480631
Platelet-Rich Plasma (PRP) has been banned in competitive athletes because ...
Status
Completed
Location
New York University Langone Orthopedic Hospital
Start Date
2010-07
Trial ID
NCT01200875
Treatments Being Tested
The relapse of acute leukemia, MDS and blast phase CML after allogeneic tra...
Status
Completed
Location
Emory University Winship Cancer Institute
Start Date
2007-01
Trial ID
NCT00548847
Treatments Being Tested
This study was a multicenter, prospective, randomized controlled trial. In ...
Status
Unknown
Location
Zhujiang Hospiatal
Start Date
2019-09-07
Trial ID
NCT04041349
Treatments Being Tested
The primary aim of the study is to evaluate the effects of correction of an...
Status
Completed
Location
Prince of Wales Hospital
Start Date
2001-02
Trial ID
NCT00563355
Treatments Being Tested
RATIONALE: Peripheral stem cell transplantation may be able to replace immu...
Status
Terminated
Location
Robert H. Lurie Comprehensive Cancer Center, Northwestern University
Start Date
1999-09
Trial ID
NCT00005787
To estimate parameters related to clinical outcomes in a real-world seeting...
Status
Active Not Recruiting
Location
Research Site
Start Date
2024-07-23
Trial ID
NCT06376084
The purpose of this study is to evaluate the safety, tolerability and pharm...
Status
Completed
Location
Site US0006
Start Date
2014-10-14
Trial ID
NCT02175433
Treatments Being Tested
This is a single-center, prospective, single-arm, open-label phase II study...
Status
Completed
Location
Asan Medical Center
Start Date
2012-09
Trial ID
NCT01719549
Treatments Being Tested
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2008-10
Trial ID
NCT00509093